BioHealth News Archive
BIO to Put Innovation in Name
Same acronym… new innovative meaning. The Biotechnology Industry Organization… better known as BIO will soon become the Biotechnology Innovation Organization. This news release from…
Read More
New Rules Let Companies Sell Stakes to Investors of Modest Means – The New York Times
Growing companies seeking to raise up to $50 million have a new financing option, starting Friday: a process that will open some private businesses…
Read More
QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched new Investigator® STR assay kits for analysis of DNA evidence in forensic laboratories in…
Read More
University of Maryland, Baltimore, gets $3 million gift – WTOP
The University of Maryland, Baltimore, will build a new interdisciplinary education facility thanks in part to a gift from a Baltimore construction company. The…
Read More
Topol: Clinical trials offer exciting examples of convergence of digital health and drug development – MedCity NewsMedCity News
One of the exciting and frustrating things about convergence, particularly in healthcare, is that it’s tough to predict how the hybrid technologies will find…
Read More
Bioscience firm United Therapeutics plans major expansion in Silver Spring – Baltimore Business Journal
United Therapeutics Corp., one of the region's largest bioscience firms, is planning a major expansion of its Silver Spring campus with plans to hire…
Read More
Bayer bets on Johns Hopkins for eye disease R&D – FierceBiotech
German pharma giant Bayer is uniting with researchers at Johns Hopkins University to ferret out new treatments for retinal diseases, signing a 5-year deal…
Read More
Bayer HealthCare, Johns Hopkins collaborate, GSK invests $95M in cell research (Morning Read) – MedCity NewsMedCity News
Bayer HealthCare and Johns Hopkins University entered into a five-year collaboration to develop ophthalmic therapies that target retinal diseases. They will work together on…
Read More
MedCity ENGAGE 2015 – Innovation in Patient Engagement
72% percent of health IT leaders think consumer and patient considerations are the most important business issue affecting care delivery. Registrants can now save…
Read More
Escape the Summer heat at our June BioBuzz!
BioBuzz is an ongoing monthly networking group of professionals from all sectors of the Biotech/Pharma/Life-sciences industries. Each month we host a FREE event for…
Read More
A deeper understanding of corporate venture capital in healthcare (finally!) – MedCity NewsMedCity News
Lake Whillans, in an effort to help level the playing field for entrepreneurs in the new world of healthcare investing, has partnered with MedCity…
Read More
GlaxoSmithKline could reportedly be targeted by Roche, Johnson & Johnson- DigitalLook.com
Pharmaceuticals giant GlaxoSmithKline could reportedly become the latest takeover target in the industry. According to the Daily Mail, market participants are speculating that the…
Read More
Yali Friedman named one of the 100 most influential people in biotechnology by Scientific American #BIO2015 – BiotechBlog
Scientific American has released its list of the 100 most influential people in biotechnology. I am honored to be included in this exclusive list and recognized for…
Read More
Which roles will stand out in new army of healthcare workers? – MedCity NewsMedCity News
There is always talk, sometimes tongue-in-cheek but mostly sort of serious, that a lot of jobs will be replaced by robots or computers. Maybe…
Read More
Aledade Inc. raises $30M from ARCH Venture Partners, Venrock – Washington Business Journal
Only a year after its founding, Bethesda-based health tech company Aledade Inc. raised $30 million in a Series B fundraising, it announced Monday. ARCH…
Read More